SCHEMBL238010

SCHEMBL238010

CC(C)(O)C(C)(C)OB(O)C1=CCCCC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2519380 0.98
SCHEMBL1870613 0.95
SCHEMBL19874014 0.77 ALDH1A1 (0.30)
SCHEMBL18686660 0.74
SCHEMBL518682 0.74
SCHEMBL3902351 0.74
SCHEMBL4561308 0.74 TSHR (0.36)
SCHEMBL2522575 0.73 QDPR (0.34)
Hydrochloric Acid SCHEMBL17181764 0.73 BLM (0.35)
SCHEMBL1799515 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 301 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20130059210-A1 ELECTROLYTE FOR RECHARGEABLE LITHIUM BATTERY AND RECHARGEABLE LITHIUM BATTERY INCLUDING SAME SAMSUNG SDI CO., LTD. (KR) 2013-03-07 US claimed
US-20260147001-A1 PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES GLYPHIC BIOTECHNOLOGIES, INC. (US) 2026-05-28 US disclosed
CN-116917280-B Tetrahydronaphthalene compound, preparation method thereof and application thereof in medicine 江苏恒瑞医药股份有限公司 2026-05-12 CN disclosed
US-20260118364-A1 PROTEIN SEQUENCING VIA COUPLING OF POLYMERIZABLE MOLECULES GLYPHIC BIOTECHNOLOGIES INC (US) 2026-04-30 US disclosed
EP-3562828-B1 SUBSTITUTED PYRAZOLOPYRIMIDINONE COMPOUNDS AS PDE2 INHIBITORS DART NEUROSCIENCE LLC (US) 2026-03-18 EP disclosed
US-20260049991-A1 SINGLE-MOLECULE PEPTIDE SEQUENCING USING GUANIDINYLATING AGENTS GLYPHIC BIOTECHNOLOGIES INC (US) 2026-02-19 US disclosed
US-12552796-B2 EED inhibitor, and preparation method therefor and use thereof JING MEDICINE TECHNOLOGY (SHANGHAI) LTD. (CN) 2026-02-17 US disclosed
EP-4056570-B1 EED INHIBITOR, AND PREPARATION METHOD THEREFOR AND USE THEREOF UNIV SHANGHAI TECHNOLOGY (CN) 2026-01-07 EP disclosed
US-20250327811-A1 SINGLE-MOLECULE PEPTIDE SEQUENCING USING DITHIOESTER AND THIOCARBAMOYL AMINO ACID REACTIVE GROUPS GLYPHIC BIOTECHNOLOGIES, INC. 2025-10-23 US disclosed
US-20250313572-A1 MACROCYCLIC MCL-1 INHIBITORS AND METHODS OF USE ABBVIE INC (US) 2025-10-09 US disclosed
WO-2010068876-A1 BLUE EMITTER WITH HIGH EFFICIENCY BASED ON IMIDAZO [1,2-f] PHENANTHRIDINE IRIDIUM COMPLEXES UNIVERSAL DISPLAY CORPORATION (US) 2010-06-17 WO disclosed
US-20100148663-A1 Blue Emitter with High Efficiency Based on Imidazo[1,2-f] Phenanthridine Iridium Complexes UNIVERSAL DISPLAY CORPORATION (US) 2010-06-17 US disclosed
US-20100069354-A1 7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-18 US disclosed
US-20100069358-A1 USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-03-18 US disclosed
EP-2144877-A1 NOVEL PYRIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS THEREOF UCB Pharma, S.A. (BE) 2010-01-20 EP disclosed
EP-2125801-A1 THE USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE Eisai R&D Management Co., Ltd. (JP) 2009-12-02 EP disclosed
EP-2109611-A1 7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE Eisai R&D Management Co., Ltd. (JP) 2009-10-21 EP disclosed
WO-2008122378-A1 NOVEL PYRIDINE DERIVATIVES, PROCESSES FOR PREPARING THEM, PHARMACEUTICAL COMPOSITIONS THEREOF UCB PHARMA, S.A. (BE) 2008-10-16 WO disclosed
WO-2008095943-A1 THE USE OF 7-AZAINDOLES IN THE INHIBITION OF C-JUN N-TERMINAL KINASE EISAI R&D MANAGEMENT CO. LTD. (JP) 2008-08-14 WO disclosed
WO-2008095944-A1 7-AZAINDOLE DERIVATIVES AND THEIR USE IN THE INHIBITION OF C-JUN N-TERMINAL KINASE EISAI R&D MANAGEMENT CO. LTD. (JP) 2008-08-14 WO disclosed